arrow
Back
C

Carlos H. Barrios

merck & company brazil

86H-index
510Paper Count
6.4WCitation Count
Published Papers 161
Publication Date
Trastuzumab deruxtecan in hormone receptor-positive, HER2-low/-ultralow metastatic breast cancer (DESTINY-Breast06): outcome analyses by time to progression on prior first-line endocrine therapy with CDK4/6 inhibitor and baseline burden of disease
err2026-03-02
err0
errOAAI
errG. Curigliano; X. Hu; R. Dent; K. Yonemori; C.H. Barrios; J.-Y. Pierga; F. Puglisi; J.-M. Ferrero; K.H. Jung; N.A. Bagegni; J. Collignon; M. Gil-Gil; X. Wu; A. Andrzejuk-Ćwik; M. Schwaederle; S. Anand; A. Bardia
errShare
errSave
Determinants of delayed postoperative radiation therapy in breast cancer patients undergoing neoadjuvant chemotherapy: A subanalysis of the AMAZONA III prospective cohort
err2026-02-01
err0
errOAAI
errPrestes, Julio Cesar; Viani, Gustavo; Gouveia, Andre Guimaraes; Silva, Mauricio Fraga Da; Moraes, Fabio Ynoe.; Rosa, Daniela Dornelles; Barrios, Carlos Henrique Escosteguy; Werutsky, Gustavo; Bines, Jose; Silva, Eduardo Henrique Cronemberger Costa E.; Queiroz, Geraldo Silva; Makdissi, Fabiana Baroni; Lima, Vladmir Cordeiro De; Freitas-Junior, Ruffo; Filho, Jose D'oliveira Couto; Emerenciano, Karla; Resende, Heloisa Magda; Crocamo, Susanne; Reinert, Tomas; Van Eyll, Brigitte; Neron, Yeni Veronica; Dybal, Vanessa; Lazaretti, Nicolas Silva; Costamilan, Rita De Cassia; Andrade, Diocesio Alves Pinto De; Mathias, Clarissa; Vacaro, Giovana Zerwes; Borges, Giuliano; Filho, Carlos Alberto Sampaio Pereira; Mano, Max Senna; Simon, Sergio Daniel; Jesus, Rafaela Gomes De; Cabalheiro, Taina; Rebelatto, Taiane Francieli; Marta, Gustavo Nader
errShare
errSave
Clinical management of common toxicities with inhibitors targeting the PI3K/AKT/mTOR pathway in breast cancer
err2026-01-27
err0
errOAAI
errK.L. Jhaveri; N.M. Iyengar; N.C. Turner; H.S. Rugo; J. O’Shaughnessy; C.H. Barrios; G. Curigliano; F. André; S.-A. Im; M.D. Goncalves; M.E. Lacouture; P.A. Fasching; R. Leung
errShare
errSave
Multidisciplinary meeting for breast cancer care: EUSOMA recommendations for optimization
err2025-12-27
err0
errOAAI
errG. Curigliano; L. Marotti; C. Barrios; N.M.L. Battisti; K.L. Cheung; S. Chia; S.L. Graff; O.J. Hartmann; I. Rubio; D. Santini; F. Sardanelli; E. Senkus; P. van Dam; M. Walker; J. Wu; C. Aristei
errShare
errSave
Adjuvant ribociclib plus nonsteroidal aromatase inhibitor therapy in patients with HR-positive/HER2-negative early breast cancer: 5-year follow-up of NATALEE efficacy outcomes and updated overall survival☆
err2025-10-17
err0
errOAAI
errJ. Crown; D. Stroyakovskii; D.A. Yardley; C.-S. Huang; P.A. Fasching; A. Bardia; S. Chia; S.-A. Im; M. Martin; B. Xu; C.H. Barrios; M. Untch; R. Moroose; S.A. Hurvitz; G.N. Hortobagyi; D.J. Slamon; F. Visco; G. Spera; J.P. Zarate; D. Halligan; Z. Li; S. Loi
errShare
errSave
Factors associated with accepting chemotherapy despite the risk of fertility loss in Latin American breast cancer patients—LACOG 0414 study
err2025-10-02
err0
errOAAI
errGustavo Werutsky; Cynthia Villarreal-Garza; Henry L. Gomez; Saúl Campos-Gómez; Rosa Ortiz Reyes; Pedro E. R. Liedke; Tomás Reinert; Vanessa Dybal; Jeovany Martinez-Mesa; Paulo Ricardo Nunes Filho; Rafaela Gomes de Jesus; Facundo Zaffaroni; Vitória Silva Garcia; Mariana Fauth Seibel; Pablo Barrios; Matheus Soares Rocha; Carlos H. Barrios
errShare
errSave
Sacituzumab Govitecan in Untreated, Advanced Triple-Negative Breast Cancer
err2025-10-01
err4
PREAI
errCortes, Javier; Punie, Kevin; Barrios, Carlos; Hurvitz, Sara A.; Schneeweiss, Andreas; Sohn, Joohyuk; Tokunaga, Eriko; Brufsky, Adam; Park, Yeon Hee; Xu, Binghe; Hegg, Roberto; Oliveira, Mafalda; Fabi, Alessandra; Vaksman, Natalya; Valdez, Theresa; Zhang, Xinrui; Lai, Catherine; Tolaney, Sara M.
errShare
errSave
Final analysis of nivolumab plus cabozantinib for advanced renal cell carcinoma from the randomized phase III CheckMate 9ER trial
err2025-09-23
err0
errOAAI
errR.J. Motzer; B. Escudier; M. Burotto; T. Powles; A.B. Apolo; M.T. Bourlon; A.Y. Shah; C. Porta; C. Suárez; C.H. Barrios; M. Richardet; H. Gurney; E.R. Kessler; Y. Tomita; J. Bedke; C. Scheffold; M. Askelson; J. Panzica; J. Zhang; M. van Kooten Losio; T.K. Choueiri
errShare
errSave
Main challenges to cancer care in Latin America: an analysis through breast cancer lenses
err2025-06-12
err0
PREAI
errGonzalo Gomez-Abuin; Pablo Mandó; Guiseppe Curigliano; Carlos H. Barrios
errShare
errSave
National cancer control plans in Latin America and the Caribbean: challenges and future directions
err2025-05-28
err0
PREAI
errCynthia Villarreal-Garza; Alejandro Aranda-Gutierrez; David G Gonzalez-Sanchez; Camila Bragança-Xavier; Gabriela Negrete-Tobar; Yanin Chavarri-Guerra; Alejandro Mohar; Carlos Barrios; Anelisa Coutinho; Ahmedin Jemal; Hedvig Hricak; Patrick Loehrer; Fabio Ynoe Moraes; Raúl Murillo
errShare
errSave
Germline Genetic Testing in Breast Cancer: Utilization and Disparities in a Middle-Income Country
err2025-03-01
err0
errOAAI
errde Souza, Alessandra Borba Anton; Barrios, Carlos; de Jesus, Rafaela Gomes; Reinert, Tomas; Giacomazzi, Juliana; Rosa, Daniela D.; Cronemberger, Eduardo; Werutsky, Gustavo; Bines, Jose; Queiroz, Geraldo Silva; de Lima, Vladmir Cordeiro; Freitas-Junior, Ruffo; Couto Filho, Jose d'Oliveira; Emerenciano, Karla; Resende, Heloisa; Crocamo, Susanne; Van Eyll, Brigitte; Neron, Yeni; Dybal, Vanessa; Lazaretti, Nicolas Silva; Costamilan, Rita de Cassia; de Andrade, Diocesio Alves Pinto; Mathias, Clarissa; Vacaro, Giovana Zerwes; Borges, Giuliano; Morelle, Alessandra Menezes; Sampaio Filho, Carlos Alberto; Mano, Max; Lichtenfels, Martina; Simon, Sergio D.; Fay, Andre P.
errShare
errSave
Prognostic variables for risk of recurrence in patients (pts) with HR+/HER2-early breast cancer (EBC) using data from the NATALEE trial: a machine learning (ML) model-based analysis
errBREAST
IF7.9
err2025-02-01
err0
errOAAI
errFasching, P. A.; Barrios, C. H.; Lim, E.; Graff, S. L.; Chia, S.; Frenel, J. -s.; Im, S. -a.; Huang, C. -s.; Ring, A.; Nowecki, Z.; Liu, Q.; Akdere, M.; Zarate, J. P.; Hu, H.; Pantoja, K.; O'Shaughnessy, J. A.
errShare
errSave
Nivolumab plus ipilimumab versus sunitinib for fi rst-line treatment of advanced renal cell carcinoma: extended 8-year follow-up results of efficacy and safety from the phase III CheckMate 214 trial
err2024-11-01
err0
errOAAI
errTannir, N. M.; Albiges, L.; Mcdermott, D. F.; Burotto, M.; Choueiri, T. K.; Hammers, H. J.; Barthelemy, P.; Plimack, E. R.; Portat, C.; George, S.; Donskov, F.; Atkins, M. B.; Gurney, H.; Kollmannsberger, C. K.; Grimm, M. -o.; Barrios, C.; Tomita, Y.; Castellano, D.; Gruenwald, V.; Rini, B. I.; Jiang, R.; Desilva, H.; Fedorov, V.; Lee, C. -w.; Motzer, R. J.
errShare
errSave
6th and 7th International consensus guidelines for the management of advanced breast cancer (ABC guidelines 6 and 7)
errBREAST
IF7.9
err2024-08-01
err22
errOAAI
errCardoso, Fatima; Paluch-Shimon, Shani; Schumacher-Wulf, Eva; Matos, Leonor; Gelmon, Karen; Aapro, Matti S.; Bajpai, Jyoti; Barrios, Carlos H.; Bergh, Jonas; Bergsten-Nordstrom, Elizabeth; Biganzoli, Laura; Cardoso, Maria Joao; Carey, Lisa A.; Chavez-MacGregor, Mariana; Chidebe, Runcie; Cortes, Javier; Curigliano, Giuseppe; Dent, Rebecca A.; El Saghir, Nagi S.; Eniu, Alexandru; Fallowfield, Lesley; Francis, Prudence A.; Millan, Sandra X. Franco; Gilchrist, Jenny; Gligorov, Joseph; Gradishar, William J.; Haidinger, Renate; Harbeck, Nadia; Hu, Xichun; Kaur, Ranjit; Kiely, Belinda; Kim, Sung-Bae; Koppikar, Smruti; Kuper-Hommel, Marion J. J.; Lecouvet, Frederic E.; Mason, Ginny; Mertz, Shirley A.; Mueller, Volkmar; Myerson, Claire; Neciosup, Silvia; Offersen, Birgitte, V; Ohno, Shinji; Pagani, Olivia; Partridge, Ann H.; Penault-Llorca, Frederique; Prat, Aleix; Rugo, Hope S.; Senkus, Elzbieta; Sledge, George W.; Swain, Sandra M.; Thomssen, Christoph; Vorobiof, Daniel A.; Vuylsteke, Peter; Wiseman, Theresa; Xu, Binghe; Costa, Alberto; Norton, Larry; Winer, Eric P.
errShare
errSave
The somatic mutation profile of estrogen receptor-positive HER2-negative metastatic breast cancer in Brazilian patients
err2024-06-17
err2
errOAAI
errReinert, Tomas; do Rego, Fernanda Orpinelli; Silva, Matheus Costa e; Rodrigues, Amanda Muniz; Koyama, Fernanda Christtanini; Goncalves, Aline Coelho; Pauletto, Maiane Maria; de Carvalho Oliveira, Leandro Jonata; de Resende, Cristiano Augusto Andrade; Landeiro, Luciana Castro Garcia; Barrios, Carlos Henrique; Mano, Max Senna; Dienstmann, Rodrigo
errShare
errSave
Ribociclib (RIB) plus nonsteroidal aromatase inhibitor (NSAI) as adjuvant treatment in patients with HR+/HER2-early breast cancer: final invasive disease-free survival (iDFS) analysis from the NATALEE trial
err2024-05-02
err3
PREAI
errHortobagyi, Gabriel; Stroyakovsky, Daniil; Yardley, Denise; Huang, Chiun-Shen; Fasching, Peter A.; Crown, John; Bardia, Aditya; Chia, Stephen; Im, Seock-Ah; Martin, Miguel; Loi, Sherene; Xu, Binghe; Hurvitz, Sara; Barrios, Carlos; Untch, Michael; Moroose, Rebecca; Visco, Frances; Parnizari, Federico; Ghaznawi, Farhat; Li, Zheng; Waters, Sorcha; Chakravartty, Arunava; Slamon, Dennis
errShare
errSave
ASCENT-07: A phase 3, randomized, open-label study of sacituzumab govitecan versus treatment of physician's choice in patients with HR+/HER2-inoperable, locally advanced, or metastatic breast cancer post-endocrine therapy
err2024-05-02
err1
PREAI
errRugo, Hope; Cortes, Javier; Curigliano, Giuseppe; Barrios, Carlos; Punie, Kevin; Park, Yeon; Iwata, Hiroji; Young, Alex; Ren, Xuehan; Cinar, Pelin; Jhaveri, Komal
errShare
errSave
Safety evaluation from the KEYNOTE-355 study of pembrolizumab plus chemotherapy vs placebo plus chemotherapy in patients with previously untreated, locally recurrent inoperable or metastatic triple-negative breast cancer
err2024-05-02
err0
PREAI
errRugo, Hope; Schmid, Peter; Nowecki, Zbigniew; Cescon, David; Im, Seock-Ah; Yusof, Mastura; Gallardo, Carlos; Iwata, Hiroji; Barrios, Carlos; Loi, Sherene; Zhou, Xuan; Zhang, Xiaoli; Pan, Wilbur; Karantza, Vassiliki; Cortes, Javier
errShare
errSave
INAVO121: Phase III study of inavolisib plus fulvestrant vs alpelisib plus fulvestrant in patients with hormone receptorpositive, HER2-negative, PIK3CAmutated locally advanced or metastatic breast cancer
err2024-05-02
err0
PREAI
errJuric, Dejan; Kalinsky, Kevin; Im, Seock-Ah; Ciruelos, Eva; Bianchini, Giampaolo; Barrios, Carlos; Jacot, William; Schmid, Peter; Loi, Sherene; Rugo, Hope; Craine, Veronica; Hutchinson, Katherine; Flechais, Aulde; Thanopoulou, Eirini; Harbeck, Nadia
errShare
errSave
Safety evaluation from the KEYNOTE-522 study of neoadjuvant pembrolizumab (or placebo) plus chemotherapy followed by adjuvant pembrolizumab (or placebo) in patients with early triple-negative breast cancer (TNBC)
err2024-05-02
err0
PREAI
errCortes, Javier; Dent, Rebecca; Pusztai, Lajos; McArthur, Heather; Kuemmel, Sherko; Denkert, Carsten; Park, Yeon Hee; Hui, Rina; Takahashi, Masato; Barrios, Carlos; Zhu, Yalin; Zhang, Xiaoli; Pan, Wilbur; Karantza, Vassiliki; O'Shaughnessy, Joyce; Schmid, Peter
errShare
errSave